The customer alleged a variance between the inratio inr result and the laboratory inr result.On (b)(6) 2015 at 8:54 am, a patient was tested on the facility's inratio monitor and the inr result was 2.0.Reportedly, multiple drops of blood was applied to the inratio testing strip.This is considered to be an improper technique when performing the inratio test.At 5:00 pm, the patient was hospitalized for coumadin toxicity (laboratory inr=7.2) and abdominal pain (kidney cyst hemorrhage).Treatment included discontinuation of coumadin, normal saline bolus, zofran 4mg iv, morphine 5mg iv, vitamin k 10mg, k-dur 40 meq orally and a normal saline with potassium infusion.The patient recovered and was discharged from the hospital on (b)(6) 2015.There was no additional information provided.
|
Investigation/conclusion: the meter and strips associated with the complaint were returned for investigation.The customer's complaint was not confirmed during in-house testing.Returned and retain strips tested on the returned meter met accuracy criteria.When reviewing in-house testing for lot 369159a, no product deficiency was found.A review of the manufacturing records for lot 369159a did not uncover any non-conformances.The lot meets release specification.The returned meter passed functional and thermistor testing during in-house investigation.Although an improper technique was identified in the complaint, root cause is unable to be determined from the information provided.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
|